CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India

Novo Nordisk

Status: Completed

Conditions: Type 2 Diabetes Mellitus

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT07121114

U1111-1310-3556 (Other Identifier)

DAS-8323

Details and patient eligibility

About

This is a cross-sectional study assessing the prevalence of Cardiovascular Disease and describing cardio-renal risk factors among individuals with Type 2 Diabetes Mellitus in India based on medical records.

Enrollment: 1,500 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female individuals with type 2 diabetes mellitus (T2DM), aged above or equal to 18 years.
• A confirmed diagnosis of T2DM before ethical clearance at every participating institution.
• Medical records available between 01 January 2024 to 30 September 2024 ought to have the data points required for the primary and secondary objectives. Medical records must have at least 6 months (greater than or equal to 180 days) of follow-up data from the date of diagnosis.

Exclusion criteria

• Diagnosis of Type 1 diabetes, or maturity-onset diabetes of the young (MODY).
• Known congenital heart disease or malformation.

Trial design

1,500 participants in 1 patient group

Cohort 1

Description:

The population consists of male and female adults who have been diagnosed with type 2 diabetes mellitus (T2DM).

Treatment:

Other: No treatment given